Nektar Therapeutics NKTR Q1 2026 Disappoints EPS 182 Below 163 Views Could Halifax Disappear from UK High Streets Lloyds Reviews Branding Strategy Jim Cramer Warns SpaceX IPO Could Be Destructive for Broader Market CorMedix CRMD Q1 2026 Earnings Beat Revenue NA EPS 049 Western Copper and Gold WRN Slides 243 as Commodity Headwinds Persist Rani Therapeutics RANI Plunges Nearly 10 as Stock Tests Critical Support Level Axiom Intelligence Acquisition Corp 1 Rights AXINR Slide 894 Support Test in Play Title Eastern Company EML Holds Steady at 2126 as Support and Resistance Levels Remain Key